Mycobacterium xenopi, a new comer?;Mycobacterium xenopi, un nouveau venu?

Revue du Praticien

Volumn 48, Issue 7, 1998, Pages 701-703

  Grosset, Jacques ^a   Truffot Pernot, Chantal ^a  

^a Lab Biol Physiopathol Cranio F   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CLARITHROMYCIN; ETHAMBUTOL; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPARFLOXACIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

BACTERIOLOGY; LUNG INFECTION; MYCOBACTERIOSIS; MYCOBACTERIUM XENOPEI; OPPORTUNISTIC INFECTION; SHORT SURVEY;

ANIMALS; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; CROSS INFECTION; CULTURE MEDIA; FEMALE; GUINEA PIGS; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM XENOPI; PROGNOSIS; RISK FACTORS;

EID: 0032054353     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Schwabacher H. A strain of mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus iævis, and its relation to atypical acid fast bacilli occurring in man. J Hyg (Lond) 1959; 57: 56-67.
2. Grosset J, Boisvert H, Truffot-Pernot C. Mycobactéries. In: Le Minor L, Véron M (eds). Bactériologie médicale. Paris: Flammarion, 1990: 965-1017.
3. Wolinsky E. Is Mycobacterium xenopi an emerging pathogen? Clin Infect Dis 1997; 24: 233-4.
4. Marks J, Schwabacher H. Infection due to Mycobacterium xenopi. BMJ 1965; 1: 32-3.
5. Parrot RG, Grosset JH. Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection. Tubercle 1988; 69: 47-55.
6. American thoracic society. Diagnosis and treatment of disease caused by non tuberculous mycobacteria. Am J Respir Crit Care Med 1997; 156: S 1-S 25.
7. Desbordes-Lize J, Foreye G, Lelieur GM. Contribution a l'étude de Mycobacterium xenopi, à l'occasion d'une importante endémie hospitalière. Poumon-cœur 1970; 26: 1141-82.
8. Jiva M, Jacoby HM, Weymouth LA, Kaminski DA, Portmore AC. Mycobacterium xenopi: innocent bystander or emerging pathogen? Clin Infect Dis 1997; 24: 226-32.
9. Truffot-Pernot C, Lecceur HF, Maury L, Dautzenberg B, Grosset J. Results of blood cuiture for detection of mycobacteria in AIDS patients. Tubercle 1989; 70: 187-91.
10. Miller WC, Perkins MD, Richardson WJ, Sexton DJ. Pott's disease caused by Mycobacterium xenopi: case report and review. Clin Infect Dis 1994; 19: 1024-8.
11. Desplaces N, Mamoudy P, Leonard P et al. Épidémie de spondylodlscites à Mycobacterium xenopi après traitement discal percutané (Résumé). Rev Rhum (Ed.fr.) 1994; 61: 775.
12. Roche B, Rozenberg S, Cambau E et al. Efficacité de l'association clarithromycine et sparfioxacine dans ie traitement d'une spondylodiscite à Mycobocterium xenopi. Rev Rhum (ed.fr.) 1997; 64: 68-9.